UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934

                               Visteon Corporation
--------------------------------------------------------------------------------
                                (Name of Issuer)

                          Common Stock, $1.00 par value
--------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                    92839U107
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                               David Metzman, Esq.
                       c/o Aurelius Capital Management, LP
                         535 Madison Avenue, 22nd Floor
                            New York, New York 10022
                                 (646) 445-6590

                                 with a copy to:

                               Jason Kaplan, Esq.
                            Schulte Roth & Zabel LLP
                                919 Third Avenue
                               New York, NY 10022
                                 (212) 756-2000

--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                 Communications)

                                  April 7, 2010
                               ------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[ ].

Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.

--------------------
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

                          (Continued on following pages)
                               (Page 1 of 13 Pages)



----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 2 of 13 Pages
----------------------------                        ----------------------------
------------- -----------------------------------------------------------------
     1        NAME OF REPORTING PERSON

              Aurelius Capital Partners, LP

------------- -----------------------------------------------------------------
     2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) | |  (b) |X|

------------- -----------------------------------------------------------------
     3        SEC USE ONLY
------------- -----------------------------------------------------------------
     4        SOURCE OF FUNDS

              WC
------------- -----------------------------------------------------------------
     5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
              TO ITEMS 2(d) or 2(e)     | |
------------- -----------------------------------------------------------------
     6        CITIZENSHIP OR PLACE OF ORGANIZATION

              Delaware
------------- -----------------------------------------------------------------
 NUMBER OF    7           SOLE VOTING POWER

   SHARES                 0
              ----------- -----------------------------------------------------
BENEFICIALLY  8           SHARED VOTING POWER

   OWNED                  5,218,092
              ----------- -----------------------------------------------------
  BY EACH     9           SOLE DISPOSITIVE POWER

 REPORTING                0
              ----------- -----------------------------------------------------
  PERSON      10          SHARED DISPOSITIVE POWER

                          5,218,092
------------- ----------- -----------------------------------------------------
     11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               5,218,092
------------- -----------------------------------------------------------------
     12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES | |
------------- -----------------------------------------------------------------
     13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

              4.00%
------------- -----------------------------------------------------------------
     14       TYPE OF REPORTING PERSON
              PN
------------- -----------------------------------------------------------------



----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 3 of 13 Pages
----------------------------                        ----------------------------
------------- -----------------------------------------------------------------
     1        NAME OF REPORTING PERSON

              Aurelius Capital International, Ltd.

------------- -----------------------------------------------------------------
     2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) | |  (b) |X|

------------- -----------------------------------------------------------------
     3        SEC USE ONLY
------------- -----------------------------------------------------------------
     4        SOURCE OF FUNDS

              WC
------------- -----------------------------------------------------------------
     5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
              TO ITEMS 2(d) or 2(e)     | |
------------- -----------------------------------------------------------------
     6        CITIZENSHIP OR PLACE OF ORGANIZATION

              Cayman Islands
------------- -----------------------------------------------------------------
 NUMBER OF    7           SOLE VOTING POWER

   SHARES                 0
              ----------- -----------------------------------------------------
BENEFICIALLY  8           SHARED VOTING POWER

   OWNED                  6,350,000
              ----------- -----------------------------------------------------
  BY EACH     9           SOLE DISPOSITIVE POWER

 REPORTING                0
              ----------- -----------------------------------------------------
  PERSON      10          SHARED DISPOSITIVE POWER

                          6,350,000
------------- ----------- -----------------------------------------------------
     11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               6,350,000
------------- -----------------------------------------------------------------
     12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES | |
------------- -----------------------------------------------------------------
     13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

              4.87%
------------- -----------------------------------------------------------------
     14       TYPE OF REPORTING PERSON
              CO
------------- -----------------------------------------------------------------





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 4 of 13 Pages
----------------------------                        ----------------------------
------------- -----------------------------------------------------------------
     1        NAME OF REPORTING PERSON

              Aurelius Convergence Fund, Ltd.

------------- -----------------------------------------------------------------
     2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ||  (b) |X|

------------- -----------------------------------------------------------------
     3        SEC USE ONLY
------------- -----------------------------------------------------------------
     4        SOURCE OF FUNDS

              WC
------------- -----------------------------------------------------------------
     5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
              TO ITEMS 2(d) or 2(e)     | |
------------- -----------------------------------------------------------------
     6        CITIZENSHIP OR PLACE OF ORGANIZATION

              Cayman Islands
------------- -----------------------------------------------------------------
 NUMBER OF    7           SOLE VOTING POWER

   SHARES                 0
              ----------- -----------------------------------------------------
BENEFICIALLY  8           SHARED VOTING POWER

   OWNED                  1,131,906
              ----------- -----------------------------------------------------
  BY EACH     9           SOLE DISPOSITIVE POWER

 REPORTING                0
              ----------- -----------------------------------------------------
  PERSON      10          SHARED DISPOSITIVE POWER

                          1,131,906
------------- ----------- -----------------------------------------------------
     11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               1,131,906
------------- -----------------------------------------------------------------
     12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES | |
------------- -----------------------------------------------------------------
     13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

              0.87%
------------- -----------------------------------------------------------------
     14       TYPE OF REPORTING PERSON
              CO
------------- -----------------------------------------------------------------





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 5 of 13 Pages
----------------------------                        ----------------------------
------------- -----------------------------------------------------------------
     1        NAME OF REPORTING PERSON

              Aurelius Capital Management, LP

------------- -----------------------------------------------------------------
     2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) | |  (b) |X|

------------- -----------------------------------------------------------------
     3        SEC USE ONLY
------------- -----------------------------------------------------------------
     4        SOURCE OF FUNDS

              AF
------------- -----------------------------------------------------------------
     5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
              TO ITEMS 2(d) or 2(e)     | |
------------- -----------------------------------------------------------------
     6        CITIZENSHIP OR PLACE OF ORGANIZATION

              Delaware
------------- -----------------------------------------------------------------
 NUMBER OF    7           SOLE VOTING POWER

   SHARES                 0
              ----------- -----------------------------------------------------
BENEFICIALLY  8           SHARED VOTING POWER

   OWNED                  12,699,998
              ----------- -----------------------------------------------------
  BY EACH     9           SOLE DISPOSITIVE POWER

 REPORTING                0
              ----------- -----------------------------------------------------
  PERSON      10          SHARED DISPOSITIVE POWER

                          12,699,998
------------- ----------- -----------------------------------------------------
     11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               12,699,998
------------- -----------------------------------------------------------------
     12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES | |
------------- -----------------------------------------------------------------
     13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

              9.74%
------------- -----------------------------------------------------------------
     14       TYPE OF REPORTING PERSON
              PN
------------- -----------------------------------------------------------------





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 6 of 13 Pages
----------------------------                        ----------------------------
------------- -----------------------------------------------------------------
     1        NAME OF REPORTING PERSON

              Mark D. Brodsky

------------- -----------------------------------------------------------------
     2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) | |  (b) |X|

------------- -----------------------------------------------------------------
     3        SEC USE ONLY
------------- -----------------------------------------------------------------
     4        SOURCE OF FUNDS

              AF
------------- -----------------------------------------------------------------
     5        CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
              TO ITEMS 2(d) or 2(e)     | |
------------- -----------------------------------------------------------------
     6        CITIZENSHIP OR PLACE OF ORGANIZATION

              United States
------------- -----------------------------------------------------------------
 NUMBER OF    7           SOLE VOTING POWER

   SHARES                 0
              ----------- -----------------------------------------------------
BENEFICIALLY  8           SHARED VOTING POWER

   OWNED                  12,699,998
              ----------- -----------------------------------------------------
  BY EACH     9           SOLE DISPOSITIVE POWER

 REPORTING                0
              ----------- -----------------------------------------------------
  PERSON      10          SHARED DISPOSITIVE POWER

                          12,699,998
------------- ----------- -----------------------------------------------------
     11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

               12,699,998
------------- -----------------------------------------------------------------
     12       CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
              SHARES | |
------------- -----------------------------------------------------------------
     13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11

              9.74%
------------- -----------------------------------------------------------------
     14       TYPE OF REPORTING PERSON
              IN
------------- -----------------------------------------------------------------




----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 7 of 13 Pages
----------------------------                        ----------------------------

ITEM 1.   SECURITY AND ISSUER

     This statement on Schedule 13D relates to the common stock, $1.00 par value
(the  "Common  Stock"),  of Visteon  Corporation,  a Delaware  corporation  (the
"Issuer").  The  principal  executive  offices of the Issuer are located at: One
Village Center Drive, Van Buren Township, Michigan, 48111.

ITEM 2.   IDENTITY AND BACKGROUND

          (a) This  statement is filed by the entities and persons listed below,
all of whom together are referred to herein as the "Reporting Persons":

          (i) Aurelius Capital Partners,  LP ("Aurelius  Capital  Partners"),  a
Delaware limited  partnership,  with respect to the shares of Common Stock owned
through ACP Master, Ltd. ("ACP Master"),  a Cayman Islands exempted company that
is a subsidiary  of Aurelius  Capital  Partners and managed by Aurelius  Capital
Management;

          (ii)  Aurelius  Capital   International,   Ltd.   ("Aurelius   Capital
International"),  a Cayman Islands exempted company,  with respect to the shares
of Common Stock owned through  Aurelius  Capital Master,  Ltd., a Cayman Islands
exempted company that is a subsidiary of Aurelius Capital International;

          (iii) Aurelius  Convergence Fund, Ltd.  ("Aurelius  Convergence Fund,"
and together with Aurelius Capital Partners and Aurelius Capital  International,
the "Aurelius  Funds"),  a Cayman Islands exempted company,  with respect to the
shares of Common Stock owned through Aurelius Convergence Master, Ltd., a Cayman
Islands exempted company that is a subsidiary of Aurelius Convergence Fund;

          (iv) Aurelius Capital Management,  LP ("Aurelius Capital Management"),
a Delaware  limited  partnership  that serves as investment  manager to Aurelius
Capital International, Aurelius Convergence Fund and ACP Master, with respect to
the shares of Common  Stock owned by Aurelius  Capital  International,  Aurelius
Convergence Fund and ACP Master; and

          (v) Mark D.  Brodsky,  who  serves as the  Senior  Managing  Member of
Aurelius  Capital  Management GP, LLC, which is the general  partner of Aurelius
Capital  Management,  with  respect to the shares of Common  Stock  owned by the
Aurelius Funds.

          (b) The address of the principal  business office of Aurelius  Capital
International and Aurelius  Convergence Fund is c/o GlobeOp  Financial  Services
(Cayman)  Limited,  45 Market  Street,  Suite 3205, 2nd Floor,  Gardenia  Court,
Camana Bay, West Bay Road South,  Grand Cayman  KY1-9003,  Cayman  Islands.  The
address of the principal business office of Aurelius Capital Partners,  Aurelius
Capital  Management and Mark D. Brodsky is 535 Madison Avenue,  22nd Floor,  New
York, NY 10022.

         (c) The  principal  business  of the  Aurelius  Funds is  investing  in
securities.  The principal  business of Aurelius Capital Management is to act as
the  investment   manager  to  Aurelius   Convergence  Fund,   Aurelius  Capital
International,  ACP Master and other related entities. The principal business of
Mark D.  Brodsky  is  serving  as Senior  Managing  Member of  Aurelius  Capital
Management GP, LLC and managing the business of the Reporting  Persons and their
affiliated entities.





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 8 of 13 Pages
----------------------------                        ----------------------------

          (d) None of the  Reporting  Persons  has,  during the last five years,
been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

          (e) None of the  Reporting  Persons  has,  during the last five years,
been  party  to a civil  proceeding  of a  judicial  or  administrative  body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment,  decree or final order enjoining future  violations of, or prohibiting
or mandating  activities  subject to, U.S.  federal or state  securities laws or
finding any violation with respect to such laws.

          (f) The  jurisdiction of organization  of Aurelius  Capital  Partners,
Aurelius Capital  International,  Aurelius Convergence Fund and Aurelius Capital
Management  is set forth in Item 2(a) above.  Mark D. Brodsky is a United States
citizen.

          Schedule A attached  hereto sets forth the  information  regarding the
general partner of Aurelius Capital Partners and Aurelius Capital Management and
the  executive  officers and  directors of Aurelius  Capital  International  and
Aurelius Convergence Fund (collectively, the "Instruction C Persons").

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

     The Common Stock  purchased by the Aurelius Funds was acquired with working
capital in open market transactions at an aggregate cost (excluding commissions,
if any) of approximately $12,404,781.61.

ITEM 4.  PURPOSE OF TRANSACTION

     The Aurelius  Funds  acquired  shares of Common Stock for investment in the
ordinary  course  of  business  because  they  believed  that the  shares,  when
purchased,   were   undervalued   and   represented  an  attractive   investment
opportunity.

     On May 28, 2009,  the Issuer and certain of its  affiliates  (collectively,
the "Debtors") filed voluntary petitions for relief under Chapter 11 of title 11
of the United States Code in the United States Bankruptcy Court for the District
of  Delaware  before the  Honorable  Christopher  S.  Sontchi  (the  "Bankruptcy
Proceedings").

     On April 14, 2010, counsel for Aurelius Capital Management sent a letter to
Issuer's counsel noting Aurelius Capital Management's  opposition to the amended
plan of reorganization  (the "Plan") on various grounds,  most  fundamentally on
the belief that the Plan rests on a valuation  of the Issuer  that,  in Aurelius
Capital  Management's  and the  market's  view,  is far  below  the  reorganized
Debtors' true value.  The letter notes that the Plan provides the holders of the
Issuer's  bank and bond  debt  with  consideration,  in the form of stock of the
reorganized  Debtors,  with a value far greater than the amount of their claims.
Aurelius  Capital  Management  noted  its  belief  that the  amended  disclosure
statement (the "Disclosure  Statement")  provides grossly  deficient  disclosure
concerning  the total  enterprise  value and  equity  value on which the Plan is
predicated.  The Aurelius  Funds  expect to file an objection to the  Disclosure
Statement and a response in support of the Creditors' Committee's pending motion
to terminate exclusivity and requested expedited discovery related thereto. The
letter  provides  that  other parties  in interest  must  be permitted to file a
plan of reorganization  and  that  the Issuer's  equity  holders, in particular,





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 9 of 13 Pages
----------------------------                        ----------------------------

must  be  permitted  to file a plan  that  gives  effect  to the  Issuer's  very
substantial value for old equity.

     The  Aurelius  Funds  intend  to  pursue  and  prosecute  the objection and
response,  described above, once filed, and may file related pleadings,  respond
to pleadings  filed by other  parties,  discuss the  formulation  of alternative
plans with other parties, serve and prosecute discovery and respond to the same,
appeal any adverse  decisions  and respond to any  appeals,  and more  generally
become  actively  involved  in the  Bankruptcy  Proceedings,  with  the  goal of
protecting  and  maximizing  the  value  of  the  Aurelius   Funds'   respective
investments.

     To the extent  permitted by  applicable  law,  rules and  regulations,  the
Reporting   Persons  may  seek  to  influence  the  outcome  of  the  Bankruptcy
Proceedings,  including,  among other things, through (i) direct and/or indirect
communications  with participants in the Bankruptcy  Proceedings and (ii) direct
and/or indirect communications with other persons,  including other stockholders
or creditors of the Issuer.

     Except as set forth herein or  as would occur upon completion of any of the
actions  discussed  herein,  none of the  Reporting  Persons  has any  plans  or
proposals which relate to, or could result in, any of the matters referred to in
paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule
13D. The  Reporting  Persons  may, at any time and from time to time,  review or
reconsider  their position and/or change their purpose and/or formulate plans or
proposals  with  respect  thereto  and  may (i)  acquire  additional  shares  or
securities of the Issuer,  (ii) dispose of any or all of their securities of the
Issuer, (iii) enter into or withdraw from legal proceedings, if any, and/or (iv)
enter into  privately  negotiated  derivative  transactions  with  institutional
counterparties to hedge the market risk of some or all of their positions in the
securities  of the Issuer,  depending  upon the factors  described  below and/or
other investment  considerations.  The Reporting  Persons disclaim all duties or
obligations, if any, to other stakeholders in the Issuer.

     In  addition,   the  Aurelius  Funds  intend  to  review  their  respective
investments  in the Issuer on a continuing  basis and may seek (although they do
not  presently  plan to do so) to influence  or change the Issuer's  management,
directors,  operations  or  business,  strategy  and future plans of the Issuer,
which may  include,  among other  things,  discussions  of  potential  strategic
alternatives and other initiatives and transactions that may become available to
the Issuer  designed  to enhance  enterprise,  shareholder  and/or the  Aurelius
Funds' respective  investment values,  including,  without  limitation,  through
potential  discussions with management,  directors,  the creditors' committee of
the Issuer, bank creditors,  other creditors,  other  shareholders,  existing or
potential  strategic  partners or competitors of the Issuer,  industry analysts,
investment  and  financing  professionals  and/or other third  parties.  For the
avoidance of doubt, the Reporting  Persons do not have any current  intention to
change or influence the control of the Issuer.




----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 10 of 13 Pages
----------------------------                        ----------------------------

Such  matters and discussions may materially affect, and result in, the Aurelius
Funds  modifying  their  respective   investments  in  the  Issuer,   exchanging
information with any of such persons pursuant to appropriate  confidentiality or
similar  agreements  or  otherwise,  working  together  with any of such persons
pursuant to joint  agreements  or otherwise,  proposing  changes in the Issuer's
operations,  governance,  capitalization  or strategic plans, or in proposing or
engaging in one or more other  actions set forth under  subsections  (a) through
(j) of Item 4 of Schedule 13D.  Factors that may  influence the Aurelius  Funds'
actions  include,  but are not limited to,  their view  regarding  the  Issuer's
operations,  business strategy,  prospects,  financial position and/or strategic
direction, the outcome of the discussions and actions referenced herein, actions
taken by the board of directors,  actions taken by the  creditors'  committee of
the  Issuer,  bank  creditors,  other  creditors,  other  shareholders  or other
persons;  developments  in the  Issuer's  bankruptcy  case;  price levels of the
Common Stock and other securities; subsequent developments affecting the Issuer;
the  circumstances   applicable  to  the  respective  Aurelius  Funds  (such  as
availability of funds, portfolio management,  tax and regulatory considerations,
investment  objectives,   and  other  investment  and  business  opportunities),
conditions  in the  securities  and debt market,  general  economic and industry
conditions and other factors that the Aurelius Funds may deem relevant from time
to time.





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 11 of 13 Pages
----------------------------                        ----------------------------

ITEM 5.       INTEREST IN SECURITIES OF THE ISSUER

     (a),(b)  The  information  set forth in Rows 7 through 13 of the cover page
hereto  for each  Reporting  Person is  incorporated  herein by  reference.  The
percentage  amount set forth in Row 13 for all cover  pages  filed  herewith  is
calculated based on 130,324,581  shares of Common Stock outstanding as set forth
in the Annual  Report on Form 10-K for the fiscal year ended  December  31, 2009
filed by the Issuer on February 26, 2010.

     (c) The Aurelius Funds entered into transactions in the Common Stock within
the last sixty days which are set forth on  Schedule B. The  Aurelius  Funds are
the only Reporting Persons to have effected  transactions in the Common Stock in
the past sixty days.

     (d) No person other than the  Reporting  Persons is known to have the right
to receive,  or the power to direct the receipt of dividends  from,  or proceeds
from the sale of, such shares of Common Stock.

     (e) Not applicable.





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 12 of 13 Pages
----------------------------                        ----------------------------

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
        SECURITIES OF THE ISSUER

     Pursuant to Rule 13d-1(k) promulgated under the Exchange Act, the Reporting
Persons have entered into an agreement  with respect to the joint filing of this
statement,  and any amendment or amendments  hereto, a copy of which is attached
hereto as Exhibit 1.

     Except  as  described   above,   there  are  no  contracts,   arrangements,
understandings or relationships (legal or otherwise) among the Reporting Persons
or between such persons and any other person with respect to any  securities  of
the  Issuer,  including  but  not  limited  to the  transfer  or  voting  of any
securities  of the  Issuer,  finder's  fees,  joint  ventures,  loan  or  option
arrangements,  puts or calls,  guarantees  of profits,  divisions  of profits or
loss, or the giving or withholding of proxies.

ITEM 7.       MATERIAL TO BE FILED AS EXHIBITS

     The following documents are filed as exhibits:

1.  Joint  Filing  Statement  Pursuant  to Rule  13d-1(k)  under the  Securities
Exchange Act of 1934, as amended.





----------------------------                        ----------------------------
CUSIP No.  92839U107            SCHEDULE 13D        Page 13 of 13 Pages
----------------------------                        ----------------------------

                                    Signature

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

     Dated: April 19, 2010


AURELIUS CAPITAL PARTNERS, LP               AURELIUS CAPITAL INTERNATIONAL, LTD.

By: Aurelius Capital GP, LLC, its General   By: Aurelius Capital Management, LP,
Partner                                     solely as investment manager and not
                                            in its individual capacity

By: /s/ David Newman
    -------------------------------
Name: David Newman                          By: /s/ David Newman
Title: Chief Operating Officer                  -------------------------------
                                            Name: David Newman
                                            Title: Chief Operating Officer


AURELIUS CONVERGENCE FUND, LTD.            AURELIUS CAPITAL MANAGEMENT, LP

By: Aurelius Capital Management, LP,
solely as investment manager and not
in its individual capacity
                                           By: /s/ David Newman
By: /s/ David Newman                           --------------------------------
    -------------------------------        Name: David Newman
Name: David Newman                         Title: Chief Operating Officer
Title: Chief Operating Officer

/s/ Mark D. Brodsky
-------------------
MARK D. BRODSKY





                                   SCHEDULE A

                 INFORMATION REGARDING THE INSTRUCTION C PERSONS

          The following sets forth the name, citizenship,  principal occupation,
position and address of each director and executive  officer or general  partner
and  control  person of the  applicable  Reporting  Persons.  To the best of the
Reporting Persons' knowledge,  none of the Instruction C Persons during the last
five  years has been  convicted  in a  criminal  proceeding  (excluding  traffic
violations or other similar  misdemeanors) or been a party to a civil proceeding
of a judicial or administrative  body of competent  jurisdiction and as a result
of such  proceeding  was or is  subject  to a  judgment,  decree or final  order
enjoining future violations of, or prohibiting or mandating  activities  subject
to, U.S.  federal or state securities laws or finding any violation with respect
to such laws. To the best of the  Reporting  Persons'  knowledge,  except as set
forth in this statement on Schedule 13D, none of the  Instruction C Persons owns
any shares of Common Stock.


AURELIUS CAPITAL PARTNERS, LP

Aurelius Capital GP, LLC, the General Partner of Aurelius Capital Partners,  LP,
is a Delaware limited liability company. Its principal business is acting as the
general partner of Aurelius Capital Partners, LP. Its principal business address
is 535 Madison Avenue,  22nd Floor,  New York, NY 10022.  Mark D. Brodsky is the
Senior Managing Member of Aurelius Capital GP, LLC.


AURELIUS CAPITAL MANAGEMENT, LP

Aurelius  Capital  Management GP, LLC, the General  Partner of Aurelius  Capital
Management,  LP, is a Delaware limited liability company. Its principal business
is acting as the  general  partner  of  Aurelius  Capital  Management,  LP.  Its
principal  business  address is 535 Madison  Avenue,  22nd Floor,  New York,  NY
10022.  Mark D.  Brodsky  is the  Senior  Managing  Member of  Aurelius  Capital
Management GP, LLC.


AURELIUS CAPITAL INTERNATIONAL, LTD.

Don  Seymour,  Aldo  Ghisletta  and Ronan  Guilfoyle  serve as the  directors of
Aurelius  Capital  International.  Each has a principal  business address of dms
House, 20 Genesis Close, PO Box 31910, Grand Cayman,  KY1-1208,  Cayman Islands.
Each director is a Cayman Islands citizen.

AURELIUS CONVERGENCE FUND, LTD.

Don  Seymour,  Aldo  Ghisletta  and Ronan  Guilfoyle  serve as the  directors of
Aurelius  Convergence Fund. Each has a principal  business address of dms House,
20 Genesis Close, PO Box 31910,  Grand Cayman,  KY1-1208,  Cayman Islands.  Each
director is a Cayman Islands citizen.





                                   SCHEDULE B

TRANSACTIONS IN THE COMMON STOCK BY AURELIUS CAPITAL PARTNERS DURING THE PAST 60
DAYS

Unless otherwise indicated,  all trades were effected in the open market through
brokers.



                                                                

Date of Transaction  Shares Purchased (Sold)  Price Per Share ($)*    Price Range ($)1
-------------------  -----------------------  -------------------   ------------------

     3/18/2010                 30,343              0.7000                   N/A
     3/18/2010                202,286              0.6900                   N/A
     3/19/2010                647,624              0.7632           0.74700 -  0.78000
     3/22/2010                333,887              0.7427           0.72500 -  0.75000
     3/23/2010                 44,815              0.7766           0.76000 -  0.80000
     3/23/2010                202,784              0.8000                   N/A
     3/24/2010                 53,543              0.7934           0.77000 -  0.80000
     3/26/2010                198,506              1.0000                   N/A
     3/26/2010                198,506              1.0084           1.00000 -  1.01000
     3/29/2010                 69,207              0.9708           0.96000 -  0.98000
     3/30/2010                 16,479              0.9900                   N/A
     3/30/2010                    981              0.9900                   N/A
     3/31/2010                140,506              1.1810           1.16000 -  1.20000
      4/6/2010                200,673              0.9994           0.99000 -  1.00000
      4/7/2010                580,774              0.9612           0.86100 -  1.02000
      4/8/2010                173,277              1.0914           1.06000 -  1.10000
      4/8/2010                196,727              1.1000                   N/A
      4/9/2010                122,458              1.1374           1.10000 -  1.15000
     4/12/2010                145,783              1.1425           1.13000 -  1.15000
     4/12/2010                 74,271              1.1473           1.13000 -  1.15000
     4/13/2010                146,372              1.1130           1.08000 -  1.15000
     4/14/2010                 22,852              1.1500                   N/A
     4/14/2010                 85,465              1.1450           1.10000 -  1.15000
     4/15/2010                308,108              1.1350           1.11000 -  1.15000
     4/15/2010                192,567              1.1290           1.07000 -  1.15000
     4/16/2010                309,013              1.1004           1.07000 -  1.12000
     4/16/2010                520,285              1.0986           1.06000 -  1.11000



* Excluding commissions.









----------------------
1 The price  reported in the column  Price Per Share ($)* is a weighted  average
price  if a  price  range is  indicated  in the column  Price  Range ($).  These
shares were purchased/sold in multiple  transactions at prices between the price
ranges below.  The reporting  persons will  undertake to provide to the staff of
the Securities and Exchange Commission, upon request, full information regarding
the number of shares sold at each separate price.





TRANSACTIONS IN THE COMMON STOCK BY AURELIUS  CAPITAL  INTERNATIONAL  DURING THE
PAST 60 DAYS

Unless  otherwise indicated, all trades were effected in the open market through
brokers.



                                                                

Date of Transaction  Shares Purchased (Sold)  Price Per Share ($)*    Price Range ($)2
-------------------  -----------------------  -------------------   ------------------

     3/18/2010                 37,722              0.7000                   N/A
     3/18/2010                251,481              0.6900                   N/A
     3/19/2010                804,924              0.7632           0.74700 -  0.78000
     3/22/2010                415,032              0.7427           0.72500 -  0.75000
     3/23/2010                 55,615              0.7766           0.76000 -  0.80000
     3/23/2010                251,652              0.8000                   N/A
     3/24/2010                154,095              0.7934           0.77000 -  0.80000
     3/26/2010                256,405              1.0000                   N/A
     3/26/2010                256,405              1.0084           1.00000 -  1.01000
     3/29/2010                 89,505              0.9708           0.96000 -  0.98000
     3/30/2010                 21,281              0.9900                   N/A
     3/30/2010                  1,267              0.9900                   N/A
     3/31/2010                211,059              1.1810           1.16000 -  1.20000
      4/6/2010                262,388              0.9994           0.99000 -  1.00000
      4/7/2010                755,100              0.9612           0.86100 -  1.02000
      4/8/2010                227,243              1.0914           1.06000 -  1.10000
      4/8/2010                257,996              1.1000                   N/A
      4/9/2010                160,373              1.1374           1.10000 -  1.15000
     4/12/2010                190,844              1.1425           1.13000 -  1.15000
     4/12/2010                 97,227              1.1473           1.13000 -  1.15000
     4/13/2010                194,162              1.1130           1.08000 -  1.15000
     4/14/2010                 74,199              1.1500                   N/A
     4/14/2010                277,506              1.1450           1.10000 -  1.15000
     4/15/2010                420,452              1.1350           1.11000 -  1.15000
     4/15/2010                262,783              1.1290           1.07000 -  1.15000
     4/16/2010                135,367              1.1004           1.07000 -  1.12000
     4/16/2010                227,917              1.0986           1.06000 -  1.11000



* Excluding commissions.









----------------------
2 The price  reported in the column  Price Per Share ($)* is a weighted  average
price if a price range is indicated in the column Price Range ($).  These shares
were purchased/sold in multiple  transactions at prices between the price ranges
below.  The  reporting  persons  will  undertake  to provide to the staff of the
Securities and Exchange Commission, upon request, full information regarding the
number of shares sold at each separate price.





TRANSACTIONS IN THE COMMON STOCK BY AURELIUS CONVERGENCE FUND DURING THE PAST 60
DAYS

Unless otherwise indicated,  all trades were effected in the open market through
brokers.



                                                                

Date of Transaction  Shares Purchased (Sold)  Price Per Share ($)*     Price Range ($)3
-------------------  -----------------------  -------------------   ------------------

     3/18/2010                  6,935              0.7000                   N/A
     3/18/2010                 46,233              0.6900                   N/A
     3/19/2010                147,452              0.7632           0.74700 -  0.78000
     3/22/2010                 76,081              0.7427           0.72500 -  0.75000
     3/23/2010                 10,070              0.7766           0.76000 -  0.80000
     3/23/2010                 45,564              0.8000                   N/A
     3/24/2010                  7,362              0.7934           0.77000 -  0.80000
     3/26/2010                 45,089              1.0000                   N/A
     3/26/2010                 45,089              1.0084           1.00000 -  1.01000
     3/29/2010                 15,788              0.9708           0.96000 -  0.98000
     3/30/2010                  4,240              0.9900                   N/A
     3/30/2010                    252              0.9900                   N/A
     3/31/2010                 35,683              1.1810           1.16000 -  1.20000
      4/6/2010                 44,939              0.9994           0.99000 -  1.00000
      4/7/2010                124,126              0.9612           0.86100 -  1.02000
      4/8/2010                 39,880              1.0914           1.06000 -  1.10000
      4/8/2010                 45,277              1.1000                   N/A
      4/9/2010                 28,669              1.1374           1.10000 -  1.15000
     4/12/2010                 33,373              1.1425           1.13000 -  1.15000
     4/12/2010                 17,002              1.1473           1.13000 -  1.15000
     4/13/2010                 33,466              1.1130           1.08000 -  1.15000
     4/14/2010                  2,949              1.1500                   N/A
     4/14/2010                 11,029              1.1450           1.10000 -  1.15000
     4/15/2010                 71,440              1.1350           1.11000 -  1.15000
     4/15/2010                 44,650              1.1290           1.07000 -  1.15000
     4/16/2010                 55,620              1.1004           1.07000 -  1.12000
     4/16/2010                 93,648              1.0986           1.06000 -  1.11000



* Excluding commissions.








----------------------
3 The price  reported in the column  Price Per Share ($)* is a weighted  average
price if a price range is indicated in the column Price Range ($).  These shares
were purchased/sold in multiple  transactions at prices between the price ranges
below.  The  reporting  persons  will  undertake  to provide to the staff of the
Securities and Exchange Commission, upon request, full information regarding the
number of shares sold at each separate price.





                                    EXHIBIT 1
                             JOINT FILING STATEMENT
                        PURSUANT TO SECTION 240.13D-1(K)

The undersigned acknowledge and agree that the foregoing statement on Schedule
13D is filed on behalf of each of the undersigned and that all subsequent
amendments to this statement on Schedule 13D shall be filed on behalf of each of
the undersigned without the necessity of filing additional joint filing
statements. The undersigned acknowledge that each shall be responsible for the
timely filing of such amendments, and for the completeness and accuracy of the
information concerning him, her or it contained therein, but shall not be
responsible for the completeness and accuracy of the information concerning the
other entities or persons, except to the extent that he, she or it knows or has
reason to believe that such information is inaccurate.


     Dated: April 19, 2010


AURELIUS CAPITAL PARTNERS, LP               AURELIUS CAPITAL INTERNATIONAL, LTD.

By: Aurelius Capital GP, LLC, its General   By: Aurelius Capital Management, LP,
Partner                                     solely as investment manager and not
                                            in its individual capacity

By: /s/ David Newman
    -------------------------------
Name: David Newman                          By: /s/ David Newman
Title: Chief Operating Officer                  -------------------------------
                                            Name: David Newman
                                            Title: Chief Operating Officer


AURELIUS CONVERGENCE FUND, LTD.            AURELIUS CAPITAL MANAGEMENT, LP

By: Aurelius Capital Management, LP,
solely as investment manager and not
in its individual capacity
                                           By: /s/ David Newman
By: /s/ David Newman                           --------------------------------
    -------------------------------        Name: David Newman
Name: David Newman                         Title: Chief Operating Officer
Title: Chief Operating Officer

/s/ Mark D. Brodsky
-------------------
MARK D. BRODSKY